4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011209
CHIEF COMMERCIAL OFFICER sold 18,259 shares at $20.29 ($370,475)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-21 | Sale 10b5-1 | −18,259 | $20.29 | $370,475 | 9,415 | D |
| Open-market sales · 18,259 sh · avg $20.29 · $370,475 | |||||||
Loading xslF345X05/form4-04232025_080423.xml…